Efficient Purification of Synthetic Peptides at High and Low pH

Significance of the Topic

Synthetic peptides are a growing class of therapeutic agents, but their purification often encounters challenges related to solubility and the amphoteric nature of amino acids. Achieving high purity under both acidic and basic conditions is critical for downstream bioactivity testing, safety assessment, and regulatory compliance.

Objectives and Study Overview

This application note describes a unified workflow for developing analytical HPLC methods and scaling them to preparative purification on a single instrument. The approach leverages valve automation to switch seamlessly between low-pH and high-pH separations, enabling effective isolation of crude synthetic peptides, exemplified by angiotensin I.

Methodology and Instrumentation

The entire workflow was carried out on an Agilent 1290 Infinity II Autoscale Preparative LC/MSD system equipped with quaternary and binary pumps, UV and diode array detectors, MS flow modulator, and preparative fraction collector. Analytical tests employed Agilent InfinityLab Poroshell 120 SB-C18 and HPH-C18 columns (4.6×150 mm, 4 µm), while preparative runs used 21.2×150 mm, 4 µm columns of the same stationary phases. Mobile phases were:

• Low pH: 0.1% trifluoroacetic acid in water (A) and acetonitrile (B).
• High pH: 10 mM ammonium bicarbonate, pH 9.8 in water (A) and ACN:water 90:10 (B).

Gradient, flow rates (1.5 mL/min analytical, 32 mL/min preparative), detection at 220 nm, and MSD settings were optimized and kept consistent across pH modes. Automated valves enabled rapid switching of solvents and columns by method parameters.

Key Results and Discussion

Generic gradients (9–99% B) were first applied to diluted angiotensin I samples at both pH values. Retention data guided the design of focused shallow gradients, which significantly improved resolution between the target peptide and major impurities. The optimized analytical methods were transferred to preparative scale using Agilent’s gradient translation tool, with sample loads increased 200-fold (20–30 mg).

Preparative chromatograms revealed sharp separation of angiotensin I under both pH regimes. Fraction collection was triggered on combined UV and MS signals, with time slices of 6 s each. Reanalysis of collected fractions demonstrated that, except for the first and last slices, all fractions exceeded 95% purity by UV detection. A minor coeluting impurity, likely a deletion variant of angiotensin I, was detected only during fraction reanalysis, illustrating the value of slice collection and automated purity assessment.

Benefits and Practical Applications

• Single-system workflow eliminates instrument swaps and manual reconfiguration.
• Automated valve switching enables rapid transitions between pH modes and scales.
• Focused gradients based on analytical retention times maximize resolution and loading capacity.
• Time-slice fractionation combined with MS ensures collection of only high-purity product, reducing waste and re-runs.

Future Trends and Applications

Integrating high-resolution mass spectrometers could elucidate coeluting impurities in real time. Further automation, such as AI-driven method development, and multi-dimensional chromatographic strategies will expand applicability to more complex peptides and peptide conjugates. Continuous flow purification and online quality control may further accelerate peptide biomanufacturing.

Conclusion

This work demonstrates efficient purification of a synthetic peptide under both acidic and basic conditions using a single HPLC-MS system. Automated switching of columns and mobile phases, coupled with focused gradients and fraction reanalysis, enabled isolation of angiotensin I at >95% purity in a streamlined workflow.

References

1. Muttenthaler M. et al. Trends in Peptide Drug Discovery. Nat. Rev. Drug Discov. 2021;20:309–325.
2. Penduff P. Analytical to Preparative HPLC Method Transfer. Agilent Technologies Technical Overview. 2013;5991-2013EN.